speb/financial-data huggingface dataset:
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 155760000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 230000.00
INNOVISION.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 36690000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: -10000.00
INNOVISION.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 960000.00
INNOVISION.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 63400000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Other Payable: 313130000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 153700000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 303660000.00
INNOVISION.NS income_statement (annual, 2024-03-31) — Other Special Charges: 10000.00
INNOVISION.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Payables: 331320000.00
INNOVISION.NS cash_flow (annual, 2024-03-31) — Pension And Employee Benefit Expense: -1610000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 12670000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 223520000.00
INNOVISION.NS income_statement (annual, 2024-03-31) — Pretax Income: 109630000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
INNOVISION.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -296400000.00
INNOVISION.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 4637120000.00
INNOVISION.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 17470000.00
INNOVISION.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 8060000.00
INNOVISION.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 8060000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 18680000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 335480000.00
INNOVISION.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 0.00
INNOVISION.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 310000.00
INNOVISION.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 440000.00
INNOVISION.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 18440000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Share Issued: 23813294.00
INNOVISION.NS income_statement (annual, 2024-03-31) — Special Income Charges: -280000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 524480000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 524250000.00
INNOVISION.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -17648.45
INNOVISION.NS income_statement (annual, 2024-03-31) — Tax Provision: 6910000.00
INNOVISION.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.06
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 940000.00
INNOVISION.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: 0.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Total Assets: 1570510000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 630380000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Total Debt: 488470000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 523480000.00
INNOVISION.NS income_statement (annual, 2024-03-31) — Total Expenses: 4956450000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 1047030000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 352860000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 134710000.00
INNOVISION.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -280000.00
INNOVISION.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -280000.00
INNOVISION.NS balance_sheet (annual, 2024-03-31) — Working Capital: 305330000.00
INNOVISION.NS income_statement (annual, 2024-03-31) — Write Off: 270000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — +Operating Expense: 119260000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 39730000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — +Total Revenue: 8931310000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 2517240000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 15880000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 15880000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 772210000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 772210000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -120640000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -120640000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 0.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 0.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Amortization: 40000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 40000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 23813294.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 23813294.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Basic EPS: 12.38
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 4.63
INNOVISION.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 43000000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 14340000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 14340000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -13900000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Capital Expenditure Reported: -13900000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 4290000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 4290000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 189000000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 189000000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 68960000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 68960000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 403940000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 403940000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 35460000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 35460000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 33500000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 33500000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -275440000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 25810000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Change In Payable: -2300000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -439830000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -681830000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 28050000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Common Stock: 189000000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 189000000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 822850000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 822850000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 8347910000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2287100000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Current Assets: 1845940000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 1845940000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 720000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 720000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Current Debt: 731390000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 731390000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 732110000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 732110000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 1275430000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1275430000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Depreciation: 25220000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 25220000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 25220000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 6790000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 25220000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 6790000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 23813294.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 23813294.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Diluted EPS: 12.38
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 4.63
INNOVISION.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 294740000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 110360000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 0.00
INNOVISION.NS income_statement (annual, 2025-03-31) — EBIT: 492290000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — EBIT: 198710000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — EBITDA: 517510000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — EBITDA: 205500000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — End Cash Position: 71050000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 227290000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -224450000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of Business: 0.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -160000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 18190000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 190000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 190000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 188690000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 188690000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Gross Profit: 583400000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 230140000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Interest Expense: 101810000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 35220000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 101810000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 35220000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Interest Income: 25890000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 25890000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -76450000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 20140000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Inventory: 0.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 0.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 1613360000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1613360000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: 11310000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 51900000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 51900000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Investmentsin Subsidiariesat Cost: 100000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Subsidiariesat Cost: 100000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 15790000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 15790000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 3570000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 3570000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 59120000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 59120000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 62690000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 62690000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 100000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 100000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 158560000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 158560000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Minority Interest: -4090000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: -4090000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Minority Interests: 3090000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 790000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Net Debt: 721550000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 721550000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 0.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Net Income: 294740000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Net Income: 110360000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 294740000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 110360000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 291650000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 109570000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 294740000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 110360000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 294740000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 110360000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 390480000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 291650000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 109570000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Net Interest Income: -101810000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -35220000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 3080000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 309050000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 309050000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -101810000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -35220000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 1540000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Net PPE: 68050000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 68050000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: 450000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 822660000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 822660000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 17450000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 17450000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 44280000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 44280000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 216680000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 216680000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 517510000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 205500000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Normalized Income: 294740000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 110360000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: -210550000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Operating Income: 464140000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Operating Income: 190410000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Operating Revenue: 8931310000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 2517240000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 23813294.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 23813294.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 26830000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 26830000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 165800000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 165800000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 190000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 190000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 48990000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 28150000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 8300000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 94040000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 32940000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Other Payable: 358430000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 358430000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 302280000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 302280000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 334980000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 334980000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Other Special Charges: -160000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Payables: 374310000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Payables: 374310000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Pension And Employee Benefit Expense: 6750000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2640000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2640000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 307220000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 307220000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Pretax Income: 390480000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 163490000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -313000000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 8347910000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2287100000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 25220000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 6790000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 9320000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 9320000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 32110000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 32110000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 633850000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 633850000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 316080000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 450000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 6790000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 24980000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Share Issued: 23813294.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 23813294.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 822850000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 822850000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 822660000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 822660000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Tax Provision: 98830000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 53920000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.25
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.33
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 1350000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 1350000.00
INNOVISION.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: 0.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Total Assets: 2202950000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 2202950000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 881970000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 881970000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Total Debt: 794800000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 794800000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 818760000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 818760000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Total Expenses: 8467170000.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 2326830000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 1384190000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1384190000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 357010000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 357010000.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 108760000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 108760000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 30000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
INNOVISION.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
INNOVISION.NS balance_sheet (annual, 2025-03-31) — Working Capital: 570510000.00
INNOVISION.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 570510000.00
INNOVISION.NS income_statement (annual, 2025-03-31) — Write Off: 50000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 10050000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 943060000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -130730000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 0.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 14830000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 2430000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 189000000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 56120000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 536060000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 25300000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Cash Financial: 30820000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 189000000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1030610000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 2424660000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1440000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 1081240000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1082680000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1607580000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 170000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 194570000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 14090000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 2154560000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Investment Properties: 51590000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Investmentsin Subsidiariesat Cost: 100000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 15790000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 990000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 42710000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 43700000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 100000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 163950000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: -7280000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 1067830000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 63840000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1030440000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 22130000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 40180000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 152300000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 23813294.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 28390000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 175780000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 170000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Other Payable: 324010000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 512270000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 479940000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Payables: 334060000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 10020000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 344240000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 45090000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 841610000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 23813294.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1030610000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1030440000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 1460000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 2716580000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1073320000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 1126380000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1023330000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1693250000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 291920000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 85670000.00
INNOVISION.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 817080000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — +Operating Expense: 173060000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 61900000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — +Total Revenue: 9807760000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 2675180000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 15210000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 15210000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 1581580000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1581580000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 9310000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 9310000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 20372014.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 5.86
INNOVISION.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 71050000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -28980000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Capital Expenditure Reported: -28980000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 14130000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 14130000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 238130000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 238130000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 506630000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 506630000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2624510000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2624510000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -299450000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -23290000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Change In Payable: -680000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -513430000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -848070000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 435580000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Common Stock: 238130000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 238130000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 2941990000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2941990000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 3192520000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 9104220000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2447270000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Current Assets: 4380310000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 4380310000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 5000000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 5000000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Current Debt: 1198250000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 1198250000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 1203250000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1203250000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 1717740000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1717740000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 6370000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 6370000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Depreciation: 22510000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 22510000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 22510000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 5990000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 22510000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 5990000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 20372014.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 5.86
INNOVISION.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 369260000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 119380000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — EBIT: 588810000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — EBIT: 178610000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — EBITDA: 611320000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — EBITDA: 184600000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — End Cash Position: 506630000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 2057020000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -310720000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -50000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 160000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 160000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 75790000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 75790000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Gross Profit: 703540000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 227910000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Interest Expense: 131310000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 37120000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 131310000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 37120000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -113470000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 38380000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Inventory: 9440000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 9440000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 4178430000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 4178430000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -1339700000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 72180000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 72180000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 9310000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 9310000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 3192520000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 9130000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 9130000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 38190000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 38190000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 47320000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 47320000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 29330000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 29330000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 0.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 0.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Minority Interests: 5770000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 680000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 3192520000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Net Debt: 729810000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 729810000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 40000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Net Income: 369260000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Net Income: 119380000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 369260000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 119380000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 363490000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 118700000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 369260000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 119380000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 369260000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 119380000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 457500000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 363490000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 118700000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Net Interest Income: -131310000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -37120000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -1352000000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 445930000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 445930000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -131310000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -37120000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -635260000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 1890000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Net PPE: 75790000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 75790000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: 1010000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 2941830000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 2941830000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 10910000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 10910000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 611320000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 184600000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Normalized Income: 369260000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 119380000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: -281740000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Operating Income: 530480000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Operating Income: 166010000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Operating Revenue: 9807760000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 2675180000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 23813294.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 23813294.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 162090000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 162090000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 492910000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 492910000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 2703860000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 2703860000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 60180000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 58330000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 12600000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 150550000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 55910000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Other Properties: 75790000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 75790000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 2690000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 2690000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 2117880000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 2117880000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Payables: 15210000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Payables: 15210000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Pension And Employee Benefit Expense: 26170000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Pretax Income: 457500000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 141490000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -1620310000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 9104220000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2447270000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 22510000.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 5990000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 268310000.00
INNOVISION.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 1010000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Share Issued: 23813294.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 23813294.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
INNOVISION.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 2941990000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2941990000.00
INNOVISION.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 2941830000.00
INNOVISION.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 2941830000.00
INNOVISION.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00